{"id":11251,"date":"2013-02-13T11:44:19","date_gmt":"2013-02-13T16:44:19","guid":{"rendered":"http:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/new-york-genome-institute-selects-exemplar-lims-to-manage-next-gen-sequencing-labs\/"},"modified":"2013-02-13T11:44:19","modified_gmt":"2013-02-13T16:44:19","slug":"new-york-genome-institute-selects-exemplar-lims-to-manage-next-gen-sequencing-labs","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/transhuman-news-blog\/genome\/new-york-genome-institute-selects-exemplar-lims-to-manage-next-gen-sequencing-labs\/","title":{"rendered":"New York Genome Institute Selects Exemplar LIMS to Manage Next Gen Sequencing Labs"},"content":{"rendered":"<p><p>    BALTIMORE, Feb. 12, 2013 \/PRNewswire\/ --Exemplar LIMS has been selected as the primary lab    management and electronic lab notebook (ELN) solution for NY    Genome Center's laboratory operations. Sapio's LIMS system will initially track next    generation sequencing workflows from the Illumina family of    sequencers from request through analysis. Support    for additional next gen sequencers will be added as needed.  <\/p>\n<p>    Sapio's LIMS software will be deployed on Apple    iPads using Exemplar LIMS for Tablets solution. This    enables lab technicians to take the LIMS with them as they move    around the laboratory, improving LIMS usability and lab    technician efficiency. NY Genome Center will    also be utilizing Exemplar's Materials Management capabilities    for detailed tracking of reagent usage. NYGC will    ultimately be processing samples for both research and clinical    applications via a CLIA certified laboratory. Sapio's    experience with implementing best practices for both research    and clinical labs will accelerate the LIMS implementation in    support of these NYGC objectives.  <\/p>\n<p>    \"The team at New York Genome Center has been impressed with the    flexibility and scalability of Sapio's offerings,\" commented    NYGC President & Scientific Director Robert B. Darnell, MD,    PhD. \"With Sapio we found an entrepreneurial partner that    understands how important customer service and collaboration    are to NYGC. We look forward to working with Sapio to design a    solution for the genome center of the future.\"  <\/p>\n<p>    \"The leadership at NYGC has recognized the importance of    next generation sequencing technology for both research and    clinical applications and has assembled a top-notch team from    top to bottom. We are both honored and enthused to be    supporting the NYGC objectives with the ultimate goal of curing    diseases,\" said Kevin Cramer, VP at Sapio Sciences. \"We look    forward to working with the NYGC team towards creating a    world-class lab operation as they scale to be one of the    largest NGS facilities in the North America.\"  <\/p>\n<p>    For more information or to schedule a product demonstration,    visit <a href=\"http:\/\/www.SapioSciences.com\" rel=\"nofollow\">http:\/\/www.SapioSciences.com<\/a>.  <\/p>\n<p>    About Sapio Sciences Llc  <\/p>\n<p>    Sapio Sciences is a leading provider of LIMS and Data    Management software, enabling scientists to manage samples,    protocols, assay data and clinical trials.With    extensive expertise in genomics\/NGS labs, Exemplar LIMS breaks    new ground in its breadth of functionality and ease of    configuration. With built-in Sample Management,    Electronic Lab Notebook (ELN), scientific data management    (SDMS) and integrated analytics, Exemplar LIMS addresses the    full life cycle of samples from receipt to processing and    analysis. Sapio will continue to lead in ease of use and    breadth of functionality across its product line,    enablingorganizations toreduce costs while    increasing productivity and efficiencyof both    laboratories and researchers alike.  <\/p>\n<p>    About New York Genome Center  <\/p>\n<p>    Founded in August 2010, the New York Genome Center (NYGC) is an    independent, non-profit organization  leveraging the    collaborative resources of leading academic medical centers,    research universities, and commercial organizations. Our vision    is to transform medical research and clinical care in New York    through the creation of one of the largest genomics research    facilities in North America, integrating sequencing,    bioinformatics, and data management. For more information,    visit <a href=\"http:\/\/www.nygenome.org\" rel=\"nofollow\">http:\/\/www.nygenome.org<\/a>  <\/p>\n<p><!-- Auto Generated --><\/p>\n<p>Read more:<br \/>\n<a target=\"_blank\" href=\"http:\/\/finance.yahoo.com\/news\/york-genome-institute-selects-exemplar-141600538.html;_ylt=A2KJjajRwhtRcxAAXZD_wgt.\" title=\"New York Genome Institute Selects Exemplar LIMS to Manage Next Gen Sequencing Labs\">New York Genome Institute Selects Exemplar LIMS to Manage Next Gen Sequencing Labs<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> BALTIMORE, Feb. 12, 2013 \/PRNewswire\/ --Exemplar LIMS has been selected as the primary lab management and electronic lab notebook (ELN) solution for NY Genome Center's laboratory operations. Sapio's LIMS system will initially track next generation sequencing workflows from the Illumina family of sequencers from request through analysis.  <a href=\"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/transhuman-news-blog\/genome\/new-york-genome-institute-selects-exemplar-lims-to-manage-next-gen-sequencing-labs\/\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[25],"tags":[],"class_list":["post-11251","post","type-post","status-publish","format-standard","hentry","category-genome"],"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/posts\/11251"}],"collection":[{"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/comments?post=11251"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/posts\/11251\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/media?parent=11251"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/categories?post=11251"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/tags?post=11251"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}